Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Adicet Bio, Inc.Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)REDWOOD CITY, Calif., August 31, 2026--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced it granted an inducement award on August 31, 2026.
- SealaskaInvesting in the Future by Upholding Traditional ValuesSealaska, the Alaska Native regional corporation for Southeast Alaska, is building a future rooted in Indigenous values. By growing businesses that improve ocean health around the world, Sealaska generates sustainable revenue that is reinvested in shareholders, communities, culture and...
- Greenway Greenhouse Cannabis CorporationGreenway Reports First Quarter Fiscal 2027 Financial ResultsGreenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis for the Canadian and international medical cannabis markets, today announced its unaudited...
- Zura Bio LimitedZura Bio to Participate in the Cantor Global Healthcare ConferenceHENDERSON, Nev., August 31, 2026--Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced that members of its management team will participate in the following upcoming investor conference:
- Olema OncologyOlema Oncology to Participate in Upcoming Investor ConferencesOlema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:
- Certain BlackRock Closed-End Funds Announce Estimated Sources of DistributionsCompanies: BlackRockNEW YORK, August 31, 2026--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock En
- Enovis Corporation DallasEnovis to Participate in the 2026 Wells Fargo Healthcare ConferenceEnovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare conference on Tuesday, September 8, 2026 at the Encore Boston Harbor.
- Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement TherapyThe Canadian Vaping Association calls on Health Canada to align with the world's most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit
- MEMSCAP: H1 2026 RESULTSGRENOBLE, France, August 31, 2026--Regulatory News: MEMSCAP (Euronext Paris: MEMS), leading provider of high-accuracy, high-stability pressure sensor solutions for the aerospace and medical markets using MEMS technology (Micro Electro Mechanical Systems), today announced its revenue and results for the first half of 2026 ended June 30, 2026.
- BostonGeneBostonGene to Showcase Novel Genomic Classifier and Immunotherapy Selection Framework at SOHO 2026WALTHAM, Mass., August 31, 2026--BostonGene, developer of the leading AI model for tumor and immune biology, today announced that two abstracts have been accepted for poster presentation at Society of Hematologic Oncology (SOHO) 2026 Annual Meeting, taking place September 9 - 12 in Houston, Texas. The 14th Annual Meeting will bring together thousands of global experts to showcase practice-changing breakthroughs and practical clinical applications in blood cancer treatment.
- FDA Clearance Advances Prescription ADHD TherapeuticsKey opportunities include prescription digital therapeutics, behavioral management, cognitive training and productivity apps for children and adults, distributed through consumers, caregivers, schools, employers and healthcare providers.
- Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research directorMANHASSET, N.Y., August 31, 2026--At the Feinstein Institutes for Medical Research, clinicians and scientists produce knowledge to cure disease, conducting clinical trials and basic and translational science to improve cancer treatment. To help propel the Feinstein Institutes’ cancer research, Tobias Janowitz, MD, PhD, has been appointed director of its Institute of Cancer Research. In addition, he will take on the roles of Robert and Janet Perro Professor in Cancer Research and director of Tran